微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 7% | -17.26% | 75% | 39/159 | 4.1% | 迪哲医药 | 115.44% | 行业排名> |
| 2026-06-30 | 4% | -13.04% | 133.92% | 42/159 | 1.36% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 1.71% | -21.56% | -81.57% | 62/159 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 9.28% | -9.99% | 9.69% | 28/159 | -4.32% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 8.46% | -1.05% | 83.91% | 31/159 | 1.69% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 4.6% | -24.09% | 111.01% | 36/159 | 0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 2.18% | -19.85% | -78.86% | 51/159 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 10.31% | -11.65% | 20.58% | 29/159 | -9.4% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 8.55% | -2.84% | 41.09% | 36/159 | 4.26% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 6.06% | 11.81% | 122.79% | 27/159 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.72% | 22.52% | -76.69% | 41/159 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 11.67% | 38.27% | 32.61% | 23/159 | -0.94% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 8.8% | 81.82% | 62.36% | 32/159 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 5.42% | 185.26% | 144.14% | 36/159 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.22% | 26.14% | -73.7% | 55/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 8.44% | 44.27% | 74.38% | 52/159 | 0.84% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 4.84% | 0.83% | 154.74% | 66/159 | 2.87% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 1.9% | -36.03% | 7.95% | 88/159 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.76% | 3.53% | -69.91% | 66/159 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 5.85% | -42.76% | 21.88% | 73/159 | 0.87% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 4.8% | -41.75% | 61.62% | 80/159 | 4.45% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 2.97% | -56.71% | 74.71% | 79/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.7% | -66.99% | -83.37% | 73/159 | 2.48% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 10.22% | -62.16% | 24.03% | 52/159 | 3.82% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 8.24% | -55.65% | 20.12% | 46/159 | 3.15% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 6.86% | -44.99% | 33.2% | 36/159 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | 5.15% | 2% | -80.93% | 12/159 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 27.01% | 41.86% | 45.37% | 9/159 | 2.62% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 18.58% | 2% | 49% | 5/159 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 12.47% | 2% | -34.51% | 7/159 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2018-12-31 | 19.04% | 0.42% | 0.42% | 16/159 | 7.16% | 宏源药业 | 21.91% | 行业排名> |
| 2017-12-31 | 18.96% | -12.59% | -12.59% | 14/159 | 9.61% | 奥赛康 | 9.7% | 行业排名> |
| 2016-12-31 | 21.69% | 2% | 2% | 17/159 | 6.11% | 奥赛康 | 40.69% | 行业排名> |